EUVIMEDEUVIMED entdecken
ÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte Studie

A Novel Propyl Gallate‐Based Paclitaxel‐Coated Balloon for the Side Branch Treatment in Coronary Bifurcation Lesions

Zhifeng Yao, You Zhou iD, Jiasheng Yin, Yizhe Wu, Li Shen, Hao Lu iD, Jianying Ma, Juying Qian, Zheyong Huang, Junbo Ge iD

Catheterization and Cardiovascular Interventions · 2026

DOI: 10.1002/ccd.70290 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2026. Verfasst von Zhifeng Yao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Coronary, Cardiac Catheters, Cardiovascular Agents, Coated Materials, Biocompatible. Die Arbeit nennt 31 Literaturangaben. Gefördert von: This study was funded by the Natural Science Foundation of Xinjiang Uygur Autonomous Region (Grant No: 2022D01C652) and Mitrassist Lifesciences Limited, China..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug‐coated balloons are emerging as an important approach for the treatment of coronary bifurcation lesions (CBL).

Aims

This study aimed to evaluate the efficacy and safety of a novel paclitaxel‐coated balloon (PCB), which used propyl gallate (PG) as the excipient, in treating the side branch of de novo CBL.

Methods

In this multicenter, randomized, non‐inferiority trial, 236 patients across 17 centers were 1:1 randomized to the PG‐based PCB or iohexol‐based PCB groups. After stent deployment in the main vessel, the side branch was dilated with the allocated PCB. Angiographic follow‐up was planned at 9 months and clinical follow‐up at 12 months. The primary endpoint was diameter stenosis (DS) in the side branch during the angiographic follow‐up.

Results

DS in the side branch was 21.3 ± 23.8% in the PG group versus 21.7 ± 24.3% in the control group ( p = 0.198). After adjustment for centers, the difference of DS between the PG group and the control group was −0.11% (95% confidence interval, −6.84% to 6.62%), meeting the prespecified non‐inferiority margin of 7%. Clinical outcomes at 12 months were comparable between groups.

Conclusions

The PG‐based PCB demonstrated non‐inferior efficacy and safety in comparison with the iohexol‐based PCB for side branch treatment in de novo CBL. The PG‐based PCB could be used as a therapeutic alternative in CBL revascularization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioplasty, Balloon, CoronaryCardiac CathetersCardiovascular AgentsCoated Materials, BiocompatibleCoronary Artery DiseaseCoronary StenosisAgedFemaleHumansMaleMiddle AgedContrast MediaCoronary AngiographyIohexolPaclitaxelPropyl GallateTime FactorsTreatment Outcome

Stichwörter der Autor:innen

coronary bifurcation lesiondrug‐coated balloonpaclitaxelpropyl gallate

Substanzen

Cardiovascular AgentsCoated Materials, BiocompatibleContrast MediaIohexolPaclitaxelPropyl Gallate

Autor:innen und Institutionen

  • Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, Fudan University, Shanghai, China.
  • National Clinical Research Center for Interventional Medicine, Shanghai, China.
  • State Key Laboratory of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Key Laboratory of Viral Heart Diseases, Chinese Academy of Medical Sciences, Shanghai, China.
  • NHC Key Laboratory of Ischemic Heart Diseases, Shanghai, China.
  • Department of Cardiology, Shanghai Geriatric Medical Center, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, Fudan University, Shanghai, China.

ORCID-Profile: You Zhou, Hao Lu, Junbo Ge

Förderung

  • This study was funded by the Natural Science Foundation of Xinjiang Uygur Autonomous Region (Grant No: 2022D01C652) and Mitrassist Lifesciences Limited, China.

Zitieren

APA

Yao, Z., Zhou, Y., Yin, J., Wu, Y., Shen, L., Lu, H., Ma, J., Qian, J., Huang, Z., & Ge, J. (2026). A Novel Propyl Gallate‐Based Paclitaxel‐Coated Balloon for the Side Branch Treatment in Coronary Bifurcation Lesions. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70290

Vancouver

Yao Z, Zhou Y, Yin J, Wu Y, Shen L, Lu H, et al. A Novel Propyl Gallate‐Based Paclitaxel‐Coated Balloon for the Side Branch Treatment in Coronary Bifurcation Lesions. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70290

BibTeX
@article{Yao2026,
  author = {Yao, Zhifeng and Zhou, You and Yin, Jiasheng and Wu, Yizhe and Shen, Li and Lu, Hao and Ma, Jianying and Qian, Juying and Huang, Zheyong and Ge, Junbo},
  title = {A Novel Propyl Gallate‐Based Paclitaxel‐Coated Balloon for the Side Branch Treatment in Coronary Bifurcation Lesions},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.70290}
}
Kostenlos starten →